Dystrophin absence in Duchenne muscular dystrophy (DMD) causes severe muscle degeneration. We describe that, as consequence of fibre damage, specific muscle-miRNAs are released into the bloodstream of DMD patients and their levels correlate with the severity of the disease. The same miRNAs are abund
โฆ LIBER โฆ
Systemic mirnas as potential biomarkers for malignancy
โ Scribed by N.A. Healy; H.M. Heneghan; N. Miller; C.K. Osborne; R. Schiff; M.J. Kerin
- Book ID
- 112101824
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- French
- Weight
- 163 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
miRNAs as serum biomarkers for Duchenne
โ
Davide Cacchiarelli; Ivano Legnini; Julie Martone; Valentina Cazzella; Adele D'A
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 713 KB
Plasma miRNAS as non-invasive biomarkers
โ
V. Nisenblat; S.A. Robertson; S.F. Evans; L.M. Hull
๐
Article
๐
2012
๐
Elsevier Science
๐
English
โ 70 KB
Tetraspanin gene expression levels as po
โ
Chizuru Hirano; Masaki Nagata; Arhab A. Noman; Nobutaka Kitamura; Makoto Ohnishi
๐
Article
๐
2009
๐
John Wiley and Sons
๐
French
โ 211 KB
## Abstract Accurate assessment of malignancy in oral squamous cell carcinoma is essential to optimize treatment planning. To detect a biomarker related to malignant propensity in gingival squamous cell carcinoma (GSCC), quantitative gene expression analysis of tetraspanin family genes was conducte
A three-plasma miRNA signature serves as
โ
Liu Ouyang, Ping Liu, Shuhua Yang, Shunan Ye, Weihua Xu, Xianzhe Liu
๐
Article
๐
2012
๐
Springer US
๐
English
โ 403 KB
Validation of methods involving miRNA is
โ
Jack W. Sharkey; Daniel J. Antoine; B. Kevin Park
๐
Article
๐
2011
๐
Elsevier Science
๐
English
โ 106 KB
819 MiRNA Profiling in the Screening of
โ
I. Casanova-Salas; J. Rubio-Briones; A. Fernandez-Serra; A. Calatrava; J. Casano
๐
Article
๐
2012
๐
Elsevier Science
๐
English
โ 57 KB